Mekics멕아이씨에스

Mekics is a small medical device maker whose trailing profit has turned slightly positive at the operating level, but it still posts a net loss and its shares are down sharply over the year.

Mekics makes ventilators, respiratory therapy devices and patient monitors sold to hospitals and overseas distributors. For the twelve months to H1 2026, revenue was about ₩13.8B...

What stands out

• Trailing revenue is ₩13.8B with operating income of ₩0.5B (3.7% margin), a clear step up from the operating losses recorded in 2023 to 2025.
• Trailing net income is still negative at about -₩0.6B, and return on equity is -1.6%.
• Borrowings of ₩15.3B exceed cash of ₩3.5B, and liabilities are 51% of equity; trailing free cash flow is negative at about -₩0.3B.
• The share price is ₩1,437, down 23.6% over one year and 15.3% over three months, and about 64% below its 52-week high of ₩4,000.
• Foreign ownership eased from 5.5% to 5.2% over 60 days, and 20-day flows show foreign and institutional net selling with retail net buying.
• No dividend is paid, and the data does not include analyst ratings or price targets.

What to watch

• Results for the period after H1 2026, to see whether operating profit is sustained and net income turns positive.
• Progress of the shareholders' meeting and related proxy and notice filings from October 2026, plus the recent 5%+ holding and insider shareholding reports.
• Debt levels relative to cash and whether free cash flow improves; the data names no specific upcoming catalyst.